国际皮肤性病学杂志    2001 27 (2): 77-80   ISSN: 2096-5540  CN: 32-1880/R   脂蛋白代谢及其在银屑病中的作用 陈杲综述, 沈克慧审校, 熊邦义审校 湖北医科大学第二附属医院皮肤科 收稿日期 null  修回日期 null  网络版发布日期 null 参考文献  [1] Seishima M,Seishima M,Mori S,et al.Scrum lipid and apolipoprotein levels in patients with psoriasis.Br J Dermatol,1994,130:738-742. [2] Schopf E,Mueller JM,Ostermann T.Value of adjnvant basic therapy in chronic recurrent skin diseases.Neurodermatitis atopica/psoriasis vulgaris.Hautarzt,1995,46(7):451-454. [3] Imamura T.Takatal,Ogasawara M2 et al.Clofibrate treatment of psoriasis with hypertriglyemia-clinical,histological and laboratory analysis.NipponHifuka Gakkai Zasshi,1991,101(6):623-628. [4] Seckin D,Tokgozoglu L,Akkaya S.Are lipoprotein profile and lipoprotein(a) levels altered in men with psoriasis? J Am Acad Dermtol,1994,31(3P(1):445-449. [5] Duan H,Li Z,Mazzone T.Tumor necrosis factoralpha modulates monocyte/macrophage apoprotein E gene expression.J Clin Invest,1995,96(2):915-922. [6] Murthy S,Mathur SN,Varilek G,et al.Cvtokine regulate apolipoprotein B secretion by Caco-2 cell:differential effects of IL-6 and TGF-beta 1.Am J Physiol,1996,270:94-102. [7] Ramharack R,Barkalow D,Spahr MA.Dominant negative effect of TGFbetal and TNF-alpha on basal and IL-6 induced lipooprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures.Arterioscler Thromb Vasc Biol,1998,18(6):984-990. [8] Song H,Saito K,Fujigaki S,et al.IL-1 beta and TNF-alpha suppress apolipoprotein(apo) E secretion and apoA-I expression in HepG2 cells.Cytokine,1998,10(4):275-280. [9] Lacorte JM,Beigneux A,Parant M,et al.Repression of apoC-Ⅲ gene expression by TNF-alpha involves C/EBPdelta/NF-IL6 beta via an IL-1independent pathway.FEBS Lett,1997,415(2):217-220. [10] Whitman SC,Argmann CA,Sawyez CG,et al.Uptake of type IVh.ypertriylgceridemic VLDL by cultured macrophages is enhance by interferongamma.J Lipid Res,1999,40(6):1017-1028. [11] Kwong LK,Ridinger DN,Bandhauer M,et al.Acute dyslipoproteinemia induced by interleukin-2:Lecithin:cholesteryl acyltransferase,lipoprotein lipase,and hepatic lipase deficiencies.J Clin Endocrinol Metab,1997,82(5):1572-1581. [12] Femandez-Miranda C,Castellano G,Guijarro C,et al.Lipoprotein changes in patients with chronic hepatitis C treated with interferon-alpha.Am J Gastroenterol,1998,93(10):1901-1904. [13] Fraunberger P,Pilz G,Gremer P,et al.Association of serum tumor necrosis factor levels with decrease of cholesterol during.septic shock.Shock,1998,10(5):359-363. [14] Pajkrt D,Doran JE,Koster F,et al.Antiinflammatory effects of reconstituted high-density lipaprotein during human endotoxemia.J Exp Med.1996,184(5):1601-1608. [15] Baker PW,Rye KA,Gamble TR,et al.Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.J Lipid Res,1999,40(2):345-353. [16] Moudry R,Spycher MO,Doran JE.Reconstituted high density lipoprotein modulates adherence of polymorphonuclear leukocytes to human endothelial cells.Shock,1997,7(3):175-181. [17] Calabresi L,Franceschini G,Sirtori CR,et al.Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins.Biochem Biophys Res Commun,1997,238(1):61-65. [18] Mistry MJ,Clay MA,Kelly ME,et al.Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary.Cell Immunol,1995,160:14-23. [19] Kelly ME,Clay MA,Mistry MJ,et al.Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes:production of interleukin 2with reduced biological activity.Cell Immunol,1994,159(2):124-139. [20] Sato Y,kobori S,Sakai M,et al.Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-beta activation.Atherosclerosis,1996,125(1):15-26. [21] Poon M,Zhang X,Dunsky KG,et al.Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells.Circulation,1997,96(8):2514-2519. [22] Madej A,Okopien B,Kowalski J,et al.Levels of tumor necrosis factor alpha in serum of patients with hyperlipoproteinemia Ⅱ B befoxe and after micronized fenofibraze therapy.Pol Arch Med Wewn,1998,99(4):308-313. [23] Miyauchi H.Immunohistochemical study for the localization of apolipoprotein AI,B10O,and E in normal and psoriatic skin.Igaku Kenkyu,1991,61(2):79-86. [24] Shubha M,Shusha M,Varilek G,et al.Cytokine-mediated inhibition of apoB secretion in CaCo-2 cells.J Lipid Res,1997,38:206-216. 通讯作者: